Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

291 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
SPIOMET4HEALTH-efficacy, tolerability and safety of lifestyle intervention plus a fixed dose combination of spironolactone, pioglitazone and metformin (SPIOMET) for adolescent girls and young women with polycystic ovary syndrome: study protocol for a multicentre, randomised, double-blind, placebo-controlled, four-arm, parallel-group, phase II clinical trial.
Garcia-Beltran C, Malpique R, Andersen MS, Bas F, Bassols J, Darendeliler F, Díaz M, Dieris B, Fanelli F, Fröhlich-Reiterer E, Gambineri A, Glintborg D, López-Bermejo A, Mann C, Marin S, Obermayer-Pietsch B, Ødegård R, Ravn P, Reinehr T, Renzulli M, Salvador C, Singer V, Vanky E, Torres JV, Yildiz M, de Zegher F, Ibáñez L. Garcia-Beltran C, et al. Trials. 2023 Sep 15;24(1):589. doi: 10.1186/s13063-023-07593-6. Trials. 2023. PMID: 37715279 Free PMC article.
European survey of diagnosis and management of the polycystic ovary syndrome: full report on the ESE PCOS Special Interest Group's 2023 Questionnaire.
Livadas S, Yildiz BO, Mastorakos G, Gambineri A, Pignatelli D, Giorgino F, Andersen MS, Obermayer-Pietsch B, Macut D; ESE PCOS Special Interest Group. Livadas S, et al. Among authors: obermayer pietsch b. Eur J Endocrinol. 2024 Aug 5;191(2):134-143. doi: 10.1093/ejendo/lvae085. Eur J Endocrinol. 2024. PMID: 39099229
Efficacy and Safety of Intermittent Fasting in People With Insulin-Treated Type 2 Diabetes (INTERFAST-2)-A Randomized Controlled Trial.
Obermayer A, Tripolt NJ, Pferschy PN, Kojzar H, Aziz F, Müller A, Schauer M, Oulhaj A, Aberer F, Sourij C, Habisch H, Madl T, Pieber T, Obermayer-Pietsch B, Stadlbauer V, Sourij H. Obermayer A, et al. Diabetes Care. 2023 Feb 1;46(2):463-468. doi: 10.2337/dc22-1622. Diabetes Care. 2023. PMID: 36508320 Free PMC article. Clinical Trial.
MetSCORE: a molecular metric to evaluate the risk of metabolic syndrome based on serum NMR metabolomics.
Gil-Redondo R, Conde R, Bruzzone C, Seco ML, Bizkarguenaga M, González-Valle B, de Diego A, Laín A, Habisch H, Haudum C, Verheyen N, Obermayer-Pietsch B, Margarita S, Pelusi S, Verde I, Oliveira N, Sousa A, Zabala-Letona A, Santos-Martin A, Loizaga-Iriarte A, Unda-Urzaiz M, Kazenwadel J, Berezhnoy G, Geisler T, Gawaz M, Cannet C, Schäfer H, Diercks T, Trautwein C, Carracedo A, Madl T, Valenti L, Spraul M, Lu SC, Embade N, Mato JM, Millet O. Gil-Redondo R, et al. Among authors: obermayer pietsch b. Cardiovasc Diabetol. 2024 Jul 24;23(1):272. doi: 10.1186/s12933-024-02363-3. Cardiovasc Diabetol. 2024. PMID: 39048982 Free PMC article.
High-dose glucocorticoid treatment vs. glucocorticoid replacement in immune checkpoint inhibitor associated hypophysitis (CORTICI): an open, randomised controlled trial.
Theiler-Schwetz V, Trummer C, Schmitt L, Terbuch A, Obermayer-Pietsch B, Richtig E, Pilz S. Theiler-Schwetz V, et al. Among authors: obermayer pietsch b. Ann Med. 2025 Dec;57(1):2453829. doi: 10.1080/07853890.2025.2453829. Epub 2025 Jan 25. Ann Med. 2025. PMID: 39862267 Free article. Clinical Trial.
291 results